Literature DB >> 6345248

Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats.

S M Hampton, P Kwasowski, K Tan, L M Morgan, V Marks.   

Abstract

Male Wistar rats were pretreated with 3 ml triolein orally for 4 days in addition to their normal diet. A similar control group were allowed free access to normal laboratory food. When given an oral fat load (1 ml triolein) plasma gastric inhibitory polypeptide (GIP) and triglyceride levels were significantly higher in the fat pretreated group. Inhibition of fat-stimulated GIP release by exogenous insulin was demonstrated in the untreated control group (plasma GIP: 663 +/- 49 versus 853 +/- 92 ng/l, mean +/- SEM p less than 0.025), but pretreatment with an oral fat load abolished this effect (plasma GIP: 1008 +/- 95 versus 1116 +/- 100 ng/l, p NS). Plasma glucose levels were significantly higher in fat pretreated rats given oral fat and intraperitoneal insulin compared with untreated controls (plasma glucose nadir 2.6 +/- 0.48 versus 1.6 +/- 0.15 mmol/l, p less than 0.05). Fat-pretreated rats showed significantly higher insulin and glucose levels compared with the untreated rats when given oral glucose (plasma insulin: 6.2 +/- 1.2 versus 2.5 +/- 0.59 micrograms/l, p less than 0.01; plasma glucose: 10.2 +/- 0.39 versus 8.9 +/- 0.41 mmol/l, p less than 0.025). Pretreatment of rats on a high fat diet causes (1) increased GIP secretion in response to an oral fat load, (2) abolition of the feed-back inhibition of exogenous insulin on fat-stimulated GIP release, and (3) some degree of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345248     DOI: 10.1007/bf00282713

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Release of immunoreactive gastric inhibitory polypeptide (IR-GIP) by oral ingestion of food substances.

Authors:  I G Cleator; R H Gourlay
Journal:  Am J Surg       Date:  1975-08       Impact factor: 2.565

Review 2.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

3.  The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.

Authors:  S E Crockett; S Cataland; J M Falko; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

4.  Gut hormones in tropical malabsorption.

Authors:  H S Besterman; G C Cook; D L Sarson; N D Christofides; M G Bryant; M Gregor; S R Bloom
Journal:  Br Med J       Date:  1979-11-17

5.  Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man.

Authors:  J M Falko; S E Crockett; S Cataland; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

6.  The effect of unabsorbable carbohydrate on gut hormones. Modification of post-prandial GIP secretion by guar.

Authors:  L M Morgan; T J Goulder; D Tsiolakis; V Marks; K G Alberti
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

7.  The importance of triglyceride hydrolysis for the release of gastric inhibitory polypeptide.

Authors:  S A Ross; E A Shaffer
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

8.  Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues.

Authors:  S Sykes; L M Morgan; J English; V Marks
Journal:  J Endocrinol       Date:  1980-05       Impact factor: 4.286

9.  Endocrine pancreatic control of the release of gastric inhibitory polypeptide. A possible physiological role for C-peptide.

Authors:  J R Dryburgh; S M Hampton; V Marks
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

10.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

View more
  4 in total

1.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.

Authors:  K Miyawaki; Y Yamada; H Yano; H Niwa; N Ban; Y Ihara; A Kubota; S Fujimoto; M Kajikawa; A Kuroe; K Tsuda; H Hashimoto; T Yamashita; T Jomori; F Tashiro; J Miyazaki; Y Seino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  I R Jones; D R Owens; S Luzio; S Williams; T M Hayes
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

3.  Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice.

Authors:  Chun-Min Lo; Silvana Obici; H Henry Dong; Michael Haas; Dawnwen Lou; Dae Hyun Kim; Min Liu; David D'Alessio; Stephen C Woods; Patrick Tso
Journal:  Diabetes       Date:  2011-05-20       Impact factor: 9.461

4.  The gut hormone receptor GIPR links energy availability to the control of hematopoiesis.

Authors:  Gemma Pujadas; Elodie M Varin; Laurie L Baggio; Erin E Mulvihill; K W Annie Bang; Jacqueline A Koehler; Dianne Matthews; Daniel J Drucker
Journal:  Mol Metab       Date:  2020-05-07       Impact factor: 7.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.